Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biased agonism: An emerging paradigm in GPCR drug discovery
Zoran Ranković, Tarsis F. Brust, Laura Bohn
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 26, Iss. 2, pp. 241-250
Open Access | Times Cited: 246

Showing 1-25 of 246 citing articles:

Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1284
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid, Nicole Kennedy, Nicolette C. Ross, et al.
Cell (2017) Vol. 171, Iss. 5, pp. 1165-1175.e13
Open Access | Times Cited: 471
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Andréane Cartier, Timothy Hla
Science (2019) Vol. 366, Iss. 6463
Open Access | Times Cited: 463
Structure of the neurotensin receptor 1 in complex with β-arrestin 1
Weijiao Huang, Matthieu Masureel, Qianhui Qu, et al.
Nature (2020) Vol. 579, Iss. 7798, pp. 303-308
Open Access | Times Cited: 322
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2
András Váradi, Gina F. Marrone, Travis C. Palmer, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 18, pp. 8381-8397
Open Access | Times Cited: 272
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
Andrea Kliewer, Frank Schmiedel, Setareh Sianati, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 259
Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations
Laura M. Wingler, Matthias Elgeti, Daniel Hilger, et al.
Cell (2019) Vol. 176, Iss. 3, pp. 468-478.e11
Open Access | Times Cited: 250
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
Tarsis F. Brust, Jenny Morgenweck, Susy A. Kim, et al.
Science Signaling (2016) Vol. 9, Iss. 456
Open Access | Times Cited: 209
Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR
Laura M. Wingler, Meredith A. Skiba, Conor McMahon, et al.
Science (2020) Vol. 367, Iss. 6480, pp. 888-892
Open Access | Times Cited: 208
GPCR activation and GRK2 assembly by a biased intracellular agonist
Jia Duan, Heng Liu, Fenghui Zhao, et al.
Nature (2023) Vol. 620, Iss. 7974, pp. 676-681
Open Access | Times Cited: 56
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
Kelly A. Berg, William P. Clarke
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 10, pp. 962-977
Open Access | Times Cited: 134
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Liang Tan, Wenzhong Yan, John D. McCorvy, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9841-9878
Closed Access | Times Cited: 119
Activated protein C, protease activated receptor 1, and neuroprotection
John H. Griffin, Berislav V. Zloković, Laurent O. Mosnier
Blood (2018) Vol. 132, Iss. 2, pp. 159-169
Open Access | Times Cited: 118
Hot topics in opioid pharmacology: mixed and biased opioids
Ammar A.H. Azzam, J. McDonald, David G. Lambert
British Journal of Anaesthesia (2019) Vol. 122, Iss. 6, pp. e136-e145
Open Access | Times Cited: 111
GPCR signalling from within the cell
Yuh‐Jiin I. Jong, Steven K. Harmon, Karen L. O’Malley
British Journal of Pharmacology (2017) Vol. 175, Iss. 21, pp. 4026-4035
Open Access | Times Cited: 107
Biased signaling by endogenous opioid peptides
Ivone Gomes, Salvador Sierra, Lindsay M. Lueptow, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 21, pp. 11820-11828
Open Access | Times Cited: 103
Allostery and Biased Agonism at Class B G Protein-Coupled Receptors
Denise Wootten, Laurence J. Miller, Cassandra Koole, et al.
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 111-138
Closed Access | Times Cited: 100
Progress and challenges of selective Farnesoid X Receptor modulation
Vittoria Massafra, Roberto Pellicciari, Antimo Gioiello, et al.
Pharmacology & Therapeutics (2018) Vol. 191, pp. 162-177
Open Access | Times Cited: 99
Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
Zuzana Bologna, Jian‐peng Teoh, Ahmed Bayoumi, et al.
Biomolecules & Therapeutics (2016) Vol. 25, Iss. 1, pp. 12-25
Open Access | Times Cited: 98
Structural basis of ligand interaction with atypical chemokine receptor 3
Martin Gustavsson, Liwen Wang, Noortje van Gils, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 95
Recent advances in understanding and managing cancer pain
Marcin Chwistek
F1000Research (2017) Vol. 6, pp. 945-945
Open Access | Times Cited: 95
Biased GPCR signaling: Possible mechanisms and inherent limitations
Vsevolod V. Gurevich, Eugenia V. Gurevich
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107540-107540
Open Access | Times Cited: 93
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion
Jeffrey J. Liu, Yi-Ting Chiu, Kelly M. DiMattio, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 5, pp. 939-949
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top